Prof. Isabel Montesinos Shares Insights on BDG Testing Use

Key Clinical Takeaways:
• Beta-D-glucan functions primarily as a complementary biomarker rather than a stand-alone diagnostic tool.
• The test helps immunocompromised patients who cannot easily provide invasive respiratory samples.
• Sensitivity and negative predictive value vary, meaning a negative result cannot always completely exclude an infection.

Serum Beta-D-glucan testing requires combination with patient clinical context and other microbiological tools according to insights shared by Prof. Isabel Montesinos.

“I mainly use it as a complementary biomarker rather than as a stand-alone test,” Montesinos explained to healthcare-in-europe.com. Its true clinical value lies in combining the result with the patient’s clinical context and other microbiological tools, such as fungal culture, species-specific biomarkers, and molecular methods.

Clinical experience with Beta-D-glucan centres on three specific conditions that present distinct diagnostic challenges. These include Pneumocystis jirovecii pneumonia, candidaemia, and invasive aspergillosis, each calling for a different approach to interpretation, as reported by healthcare-in-europe.com.

The biomarker is particularly useful in immunocompromised and clinically fragile patients. This group includes individuals with haematological malignancies, transplant recipients, and patients receiving immunosuppressive therapies where obtaining invasive respiratory samples such as bronchoalveolar lavage may be difficult, contraindicated, or simply not feasible, according to healthcare-in-europe.com.

In these settings, the non-invasive serum Beta-D-glucan test is a practical advantage. A further strength is its broad, panfungal spectrum.

“BDG can support the suspicion of an invasive fungal infection without prior knowledge of the causative organism,” Montesinos told healthcare-in-europe.com, noting it serves as a useful complementary tool alongside more specific biomarkers.

However, sensitivity and negative predictive value vary across clinical settings and fungal infections. A negative result cannot always completely exclude an invasive fungal infection, and interpretation must always take account of the broader clinical and microbiological picture, as healthcare-in-europe.com noted.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.